# Let’s talk Ozempic...again! [Waterbreak]

Page: https://stenobird.com/podcast/fight-laugh-feast-usa-5063827/let-s-talk-ozempic-again-waterbreak
Text version: https://stenobird.com/podcast/fight-laugh-feast-usa-5063827/let-s-talk-ozempic-again-waterbreak.md
Podcast: [Fight Laugh Feast USA](https://stenobird.com/podcast/fight-laugh-feast-usa-5063827)
Published: 2026-09-11T13:00:00+00:00
Episode link: https://dts.podtrac.com/redirect.mp3/app.dropwave.io/episode/cfe9754d-d54f-41f2-9969-c9a5685a6a9d/lets-talk-ozempicagain.mp3
Audio file: https://dts.podtrac.com/redirect.mp3/app.dropwave.io/episode/cfe9754d-d54f-41f2-9969-c9a5685a6a9d/lets-talk-ozempicagain.mp3
Processing state: not_requested
JSON: https://stenobird.com/v1/public/podcasts/fight-laugh-feast-usa-5063827/episodes/let-s-talk-ozempic-again-waterbreak
Duration seconds: 3259

## Resource

Gabe and Annie Rench are back for round two on the biggest trend in health and fitness right now: GLP-1 drugs like Ozempic, Wegovy, Mounjaro, and Zepbound. A year after their first Ozempic episode blew up, they revisit the topic with fresh eyes — why so many people (maybe one in three women, by their guess) feel like they have no other option, what the British Medical Journal's newest research says about weight regain after stopping, and why "just eat less" is the most reductionist advice in modern medicine.   💦 IN THIS EPISODE: What GLP-1/GIP agonist drugs (semaglutide, tirzepatide, and the upcoming retatrutide) actually do in your body, chemically speaking Five real reasons so many people feel like a GLP-1 is their only option — from ignored root-cause health drivers to decades of yo-yo dieting to women's hormones being flat-out misunderstood by modern medicine Annie's own years-long thyroid journey, and why "just eat less, move more" advice fails so many people A brand-new British Medical Journal meta-analysis on rapid weight regain after stopping these drugs — and Annie's two biggest unanswered concerns about staying on them long-term Who Annie actually thinks these drugs are for, and the harm-reduction approach (lowest dose, an exit strategy, working the fundamentals alongside it) she'd want you to take if you're going to use one   ⏱️ TIMESTAMPS 00:00 – Intro & sponsor read (Kings Ridge Elderberry Farm) 00:47 – Fight Laugh Feast Conference announcement & welcome to Waterbreak 01:50 – Why we're doing an Ozempic round two 02:35 – Just how many people are actually on these drugs right now 04:59 – What GLP-1/GIP agonist drugs are: semaglutide, tirzepatide, and retatrutide 07:39 – How they work in…

## Actions

- request_transcript: `POST https://stenobird.com/v1/public/podcasts/fight-laugh-feast-usa-5063827/episodes/let-s-talk-ozempic-again-waterbreak/transcription-requests` — Idempotently request low-priority transcript generation for this episode.
- read_markdown: `GET https://stenobird.com/podcast/fight-laugh-feast-usa-5063827/let-s-talk-ozempic-again-waterbreak.md` — Read the agent-friendly Markdown representation of this episode resource.

A page view does not enqueue transcription. Agents should invoke `request_transcript` explicitly when they need this episode processed.

## Transcript

Full transcripts are not published on public pages unless there is a clear rights basis.